Tumor cells often undergo metabolic alterations characterized by increased levels of circulating free fatty acids, monacylglycerides, and diacylglycerides.[16] Therefore, we hypothesized that PDGFC might contribute to the malignant progression of PDAC through the regulation of fatty acid metabolism. The gene discussed is PDGFC; the disease is neoplasm.